vs
Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $172.2M, roughly 1.1× Acadian Asset Management Inc.). Acadian Asset Management Inc. runs the higher net margin — 20.2% vs 0.9%, a 19.2% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 2.6%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 27.6%).
United Asset Management was an American holding company headquartered in Boston, Massachusetts.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
AAMI vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $172.2M | $185.2M |
| Net Profit | $34.7M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 33.3% | 8.6% |
| Net Margin | 20.2% | 0.9% |
| Revenue YoY | 2.6% | 23.7% |
| Net Profit YoY | -18.4% | -88.5% |
| EPS (diluted) | $0.97 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $172.2M | $185.2M | ||
| Q3 25 | $144.2M | $169.1M | ||
| Q2 25 | $127.4M | $154.7M | ||
| Q1 25 | $119.9M | $125.2M | ||
| Q4 24 | $167.8M | $149.7M | ||
| Q3 24 | $123.1M | $141.5M | ||
| Q2 24 | $109.0M | $126.7M | ||
| Q1 24 | $105.7M | $110.4M |
| Q4 25 | $34.7M | $1.7M | ||
| Q3 25 | $15.1M | $17.3M | ||
| Q2 25 | $10.1M | $-24.4M | ||
| Q1 25 | $20.1M | $-21.7M | ||
| Q4 24 | $42.5M | $14.7M | ||
| Q3 24 | $16.9M | $-6.7M | ||
| Q2 24 | $11.0M | $-15.7M | ||
| Q1 24 | $14.6M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 33.3% | 8.6% | ||
| Q3 25 | 18.4% | 20.3% | ||
| Q2 25 | 12.7% | -6.1% | ||
| Q1 25 | 26.6% | -6.3% | ||
| Q4 24 | 38.7% | 10.7% | ||
| Q3 24 | 21.9% | 15.3% | ||
| Q2 24 | 18.9% | 11.8% | ||
| Q1 24 | 21.7% | -25.1% |
| Q4 25 | 20.2% | 0.9% | ||
| Q3 25 | 10.5% | 10.2% | ||
| Q2 25 | 7.9% | -15.8% | ||
| Q1 25 | 16.8% | -17.3% | ||
| Q4 24 | 25.3% | 9.8% | ||
| Q3 24 | 13.7% | -4.8% | ||
| Q2 24 | 10.1% | -12.4% | ||
| Q1 24 | 13.8% | -43.9% |
| Q4 25 | $0.97 | $0.00 | ||
| Q3 25 | $0.42 | $0.06 | ||
| Q2 25 | $0.28 | $-0.08 | ||
| Q1 25 | $0.54 | $-0.07 | ||
| Q4 24 | $1.11 | $0.05 | ||
| Q3 24 | $0.45 | $-0.02 | ||
| Q2 24 | $0.29 | $-0.05 | ||
| Q1 24 | $0.37 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | $200.0M | $392.7M |
| Stockholders' EquityBook value | — | $274.2M |
| Total Assets | $677.0M | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | $200.0M | $392.7M | ||
| Q3 25 | — | $392.0M | ||
| Q2 25 | — | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | $275.0M | $390.1M | ||
| Q3 24 | — | $389.5M | ||
| Q2 24 | — | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | — | $274.2M | ||
| Q3 25 | — | $230.4M | ||
| Q2 25 | — | $204.3M | ||
| Q1 25 | — | $193.6M | ||
| Q4 24 | — | $194.0M | ||
| Q3 24 | — | $178.8M | ||
| Q2 24 | — | $132.5M | ||
| Q1 24 | — | $130.7M |
| Q4 25 | $677.0M | $949.9M | ||
| Q3 25 | $751.4M | $868.8M | ||
| Q2 25 | $672.3M | $815.3M | ||
| Q1 25 | $677.3M | $789.8M | ||
| Q4 24 | $703.2M | $785.0M | ||
| Q3 24 | $555.2M | $786.6M | ||
| Q2 24 | $533.1M | $749.5M | ||
| Q1 24 | $544.9M | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.4M | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | -0.07× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.4M | $16.3M | ||
| Q3 25 | $-23.9M | $35.7M | ||
| Q2 25 | $61.6M | $-26.5M | ||
| Q1 25 | $-48.8M | $7.8M | ||
| Q4 24 | $55.8M | $-3.9M | ||
| Q3 24 | $69.6M | $-23.0M | ||
| Q2 24 | $45.7M | $22.7M | ||
| Q1 24 | $-40.4M | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-23.3M | ||
| Q2 24 | — | $21.6M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | — | -16.5% | ||
| Q2 24 | — | 17.0% | ||
| Q1 24 | — | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | -0.07× | 9.62× | ||
| Q3 25 | -1.58× | 2.06× | ||
| Q2 25 | 6.10× | — | ||
| Q1 25 | -2.43× | — | ||
| Q4 24 | 1.31× | -0.27× | ||
| Q3 24 | 4.12× | — | ||
| Q2 24 | 4.15× | — | ||
| Q1 24 | -2.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAMI
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
